Immunity to COVID-19 Higher Than Serological Tests Suggest
|
By HospiMedica International staff writers Posted on 06 Jul 2020 |
A new study shows that many people with mild or asymptomatic COVID-19 demonstrate a T-cell-mediated immunity, even if they have not tested positively for antibodies.
For the study, researchers at Karolinska Institutet (Solna, Sweden) and Karolinska University Hospital (KUH; Stockholm, Sweden) performed immunological analyses of samples from over 200 inpatients (many of whom had mild or no symptoms of COVID-19) at KUH, as well as their exposed asymptomatic family members who returned to Stockholm after holidaying in the Alps in March 2020. Healthy blood donors who gave blood during 2020 and 2019 (the control group) were also included.
The researchers then mapped the functional and phenotypic landscape of T-cell responses. They found that SARS-CoV-2-specific T cells were detectable in seronegative family members and individuals with a history of asymptomatic or mild COVID-19. The collective dataset showed that SARS-CoV-2 elicits robust memory T cell responses, akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 in seronegative individuals as well. The study was published on June 29, 2020, in in bioRxiv.
“T cells are a type of white blood cells that are specialized in recognizing virus-infected cells, and are an essential part of the immune system. Advanced analyses have now enabled us to map in detail the T-cell response during and after a COVID-19 infection,” said senior author Marcus Buggert, PhD, of KI. “Our results indicate that roughly twice as many people have developed T-cell immunity compared with those who we can detect antibodies in.”
“One interesting observation was that it wasn't just individuals with verified COVID-19 who showed T-cell immunity, but also many of their exposed asymptomatic family members,” said study co-author Soo Aleman, PhD, of KUH. “Moreover, roughly thirty percent of the blood donors who'd given blood in May 2020 had COVID-19-specific T cells, a figure that's much higher than previous antibody tests have shown.”
T cells are lymphocytes that originate in the bone marrow and mature in the thymus. They determine the specificity of immune response to antigens. They can be distinguished from other lymphocytes by the presence of a T-cell receptor on the cell surface. One of the more important T-cells are CD4+ helper cells which send signals to other types of immune cells, including CD8 killer cells, which then destroy the infectious particle.
Related Links:
Karolinska Institutet
Karolinska University Hospital
For the study, researchers at Karolinska Institutet (Solna, Sweden) and Karolinska University Hospital (KUH; Stockholm, Sweden) performed immunological analyses of samples from over 200 inpatients (many of whom had mild or no symptoms of COVID-19) at KUH, as well as their exposed asymptomatic family members who returned to Stockholm after holidaying in the Alps in March 2020. Healthy blood donors who gave blood during 2020 and 2019 (the control group) were also included.
The researchers then mapped the functional and phenotypic landscape of T-cell responses. They found that SARS-CoV-2-specific T cells were detectable in seronegative family members and individuals with a history of asymptomatic or mild COVID-19. The collective dataset showed that SARS-CoV-2 elicits robust memory T cell responses, akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 in seronegative individuals as well. The study was published on June 29, 2020, in in bioRxiv.
“T cells are a type of white blood cells that are specialized in recognizing virus-infected cells, and are an essential part of the immune system. Advanced analyses have now enabled us to map in detail the T-cell response during and after a COVID-19 infection,” said senior author Marcus Buggert, PhD, of KI. “Our results indicate that roughly twice as many people have developed T-cell immunity compared with those who we can detect antibodies in.”
“One interesting observation was that it wasn't just individuals with verified COVID-19 who showed T-cell immunity, but also many of their exposed asymptomatic family members,” said study co-author Soo Aleman, PhD, of KUH. “Moreover, roughly thirty percent of the blood donors who'd given blood in May 2020 had COVID-19-specific T cells, a figure that's much higher than previous antibody tests have shown.”
T cells are lymphocytes that originate in the bone marrow and mature in the thymus. They determine the specificity of immune response to antigens. They can be distinguished from other lymphocytes by the presence of a T-cell receptor on the cell surface. One of the more important T-cells are CD4+ helper cells which send signals to other types of immune cells, including CD8 killer cells, which then destroy the infectious particle.
Related Links:
Karolinska Institutet
Karolinska University Hospital
Latest Critical Care News
- Angiography-Based FFR Approach Matches Gold Standard Results Without Wires
- Eye Imaging AI Identifies Elevated Cardiovascular Risk
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
Spinal and orthopedic fusion procedures often require bone graft materials that handle predictably and support bone formation. Surgeons face added complexity in difficult anatomy and challenging fusion environments.... Read more
Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
Acute pulmonary embolism can cause rapid hemodynamic deterioration and early death in hospitalized and emergency patients. Systemic thrombolysis can dissolve clots but is limited by a high risk of major... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







